Access to anti-retroviral drugs, female in Africa Western and Central

Africa Western and Central: Access to anti-retroviral drugs, female was 83.1% in 2024. ◆ Volatile

Latest (2024)
83.1%
Change on year
up 4.6%
Rank
14th
of 19 groups
All-time high
83.1%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Africa Western and Central, 2000–2024

0204060802000201220242000: 0 %2001: 0 %2002: 0.402 %2003: 0.504 %2004: 1.5 %2005: 3.1 %2006: 5.3 %2007: 7.2 %2008: 12 %2009: 16 %2010: 19.4 %2011: 23.4 %2012: 30.1 %2013: 33.6 %2014: 38.1 %2015: 41.5 %2016: 47.5 %2017: 53 %2018: 54.9 %2019: 60 %2020: 65.2 %2021: 70.2 %2022: 75.1 %2023: 79.5 %2024: 83.1 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, female in Africa Western and Central stood at 83.1%. That is the highest value across all 25 years on record.

The figure is up 4.6% on the previous year and up 118.1% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Africa Western and Central peaked at 83.1% in 2024 and was at its lowest, 0.0%, in 2000.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in Africa Western and Central, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Africa Western and Central, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.4%
2003 0.5% +25.4%
2004 1.5% +207.2%
2005 3.1% +100.2%
2006 5.3% +72.3%
2007 7.2% +35.5%
2008 12.0% +65.7%
2009 16.0% +33.0%
2010 19.4% +21.6%
2011 23.4% +20.4%
2012 30.1% +29.0%
2013 33.6% +11.6%
2014 38.1% +13.3%
2015 41.5% +8.9%
2016 47.5% +14.6%
2017 53.0% +11.5%
2018 54.9% +3.6%
2019 60.0% +9.3%
2020 65.2% +8.6%
2021 70.2% +7.7%
2022 75.1% +6.9%
2023 79.5% +5.8%
2024 83.1% +4.6%

Biggest year-on-year movements

Years where Access to anti-retroviral drugs, female in Africa Western and Central changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2004 +207.2% 0.5% 1.5%
2005 +100.2% 1.5% 3.1%

Averages by decade

DecadeAverage LowestHighest Years
2000s 4.6% 0.0% 16.0% 10
2010s 40.2% 19.4% 60.0% 10
2020s 74.6% 65.2% 83.1% 5

Countries ranked near Africa Western and Central

  1. 12 Rwanda 97.0% compare
  2. 12 United Arab Emirates 97.0% compare
  3. 14 Liberia 96.0% compare
  4. 14 Sweden 96.0% compare
  5. 14 Togo 96.0% compare
  6. 14 United Kingdom of Great Britain and Northern Ireland 96.0% compare
  7. 14 Zambia 96.0% compare

See the full ranking of 160 places →

More gender data for Africa Western and Central

All data for Africa Western and Central →

Frequently asked questions

What is access to anti-retroviral drugs, female in Africa Western and Central?
Access to anti-retroviral drugs, female in Africa Western and Central was 83.1% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Africa Western and Central?
The highest recorded value was 83.1% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Africa Western and Central?
The lowest recorded value was 0.0% in 2000.
How does Africa Western and Central rank for access to anti-retroviral drugs, female?
Africa Western and Central ranks 14th out of 19 groups with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Africa Western and Central?
Over the last ten years it is up 118.1%. The long-run trend across the full record is volatile.
Where does this Africa Western and Central data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Africa Western and Central. Statizoid, drawing on UNAIDS estimates. Retrieved 16 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/africa-western-and-central/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/africa-western-and-central/">Access to anti-retroviral drugs, female in Africa Western and Central</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.